Novozymes A/S (NSIS-B) Fair Value & Analysis
Basic Materials · DK · Market cap 201B DKK
Fair value as of: Jul 18, 2026
From 26 valuation models · updated 4 days ago
Share price +7.5% over the past month.
Price vs Fair Value (12 months)
12‑month range kr 337.86 – kr 445.80 · fair‑value band kr 269.50 – kr 449.16 · the kr 423.60 price screens above the kr 359.32 fair value. As of Jul 18, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Novozymes A/S (NSIS-B) currently trades at kr 423.60, while our model-based Fair Value estimate is kr 359.32, implying the stock looks roughly 15.2% overvalued today. We read business quality at 62/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Novozymes A/S generated revenue of 4.2B DKK at a net margin of 14.2%. Revenue grew 3.9% year over year. It earns a return on equity of 5.4%. Net debt stands at 22.2B DKK. Fundamentals as of Jul 18, 2026
Our scenario range runs from kr 269.50 (bear case) to kr 449.16 (bull case); at kr 423.60, the current price sits within that range. The share trades about 12% below its 52-week high and 27% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -69% fair-value upside, at -15%, NSIS-B screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 18, 2026. TTM = trailing twelve months.
About the company
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women's, children's cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Novozymes A/S reported revenue of kr 4.2B in FY2025 versus kr 15.0B in FY2021, a compound −27.4%/yr. Reported net income was kr 583M in FY2025, compounding −34.4%/yr from FY2021.
Is NSIS-B fairly valued? → Check now
Recent news
- FUL or NVZMY: Which Is the Better Value Stock Right Now?
- A Look At Novozymes (CPSE:NSIS B) Valuation After Recent Share Price Weakness
- Corbion General Shareholders Meeting approves Supervisory Board appointments and dividend
- Novonesis delivered strong start to the year with 7% organic sales growth in Q1
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection, not financial advice.
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $509.16 | $159.69 | -69% |
| Nan Ya Plastics Corporation 1303 | 104.50 TWD | 4.87 TWD | -95% |
| Intercontinental Exchange, Inc I1CE34 | R$367.00 | R$311.38 | -15% |
| Wanhua Chemical Group 600309 | ¥74.30 | ¥68.03 | -8% |
| Asian Paints Limited ASIANPAINT | ₹2,674 | ₹739.38 | -72% |
| PPG Industries, Inc PPG | 1,988 MXN | 1,169 MXN | -41% |
| Solar Industries India Limited SOLARINDS | ₹17,697 | ₹2,793 | -84% |
| Pidilite Industries Limited PIDILITIND | ₹1,507 | ₹393.58 | -74% |
| PT Chandra Asri Pacific Tbk TPIA | 1,955 IDR | 2,350 IDR | +20% |
| Linde India Limited LINDEINDIA | ₹7,115 | ₹757.93 | -89% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Novozymes A/S (NSIS-B) undervalued?
What is the fair value of NSIS-B?
What is the quality score of NSIS-B?
What is the revenue of Novozymes A/S (NSIS-B)?
What is the net profit margin of NSIS-B?
Does Novozymes A/S pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Novozymes A/S analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.